Lobbying client

ROCKET PHARMACEUTICALS, INC.

Pharmaceutical company seeking gene therapy for rare diseases

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 3 of its records are shown together here.

Filings
23
Filed by
3
Reported in-house
—
Reported by firms
$330,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2019 to 2026

Filings

5 filings for 2021, newest first.
Filing Filed by Amount
4th Quarter - Report
4th Quarter 2021
MERCURY PUBLIC AFFAIRS, LLC $10,000 reported
3rd Quarter - Report
3rd Quarter 2021
MERCURY PUBLIC AFFAIRS, LLC $10,000 reported
2nd Quarter - Report
2nd Quarter 2021
MERCURY PUBLIC AFFAIRS, LLC $10,000 reported
1st Quarter - Report
1st Quarter 2021
MERCURY PUBLIC AFFAIRS, LLC — reported
Registration
1st Quarter 2021
MERCURY PUBLIC AFFAIRS, LLC — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
THE KPM GROUP DC LLC 8 $170,000
MAYER BROWN LLP 5 $110,000
MERCURY PUBLIC AFFAIRS, LLC 7 $50,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 7
Immigration IMM 5
Pharmacy PHA 2

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 2666 118th 2
S. 4583 118th 2
S. 4204 118th 2
H.R. 9184 118th 2
H.R. 7384 118th 2

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.